24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Startup: Confidential
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Cukierman
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
14:00
Musk’s potential role as government efficiency czar stirs concerns over power consolidation
11:28
“Investors who have historically invested in Israel continue to invest and, in some cases, have doubled down”
08:54
Generative AI: The destructive power and opportunities in the geopolitical arena
17:01
OneStep secures $36 million Series B for smartphone-based motion analysis technology
More stories
Buzz
Most popular
Daily
Weekly
1
Wiz will be bigger than CrowdStrike and Palo Alto: Cyber decacorn's top female executive shares her vision
2
BiltOn, founded by ex-Sayeret Matkal officers, nets $15M Series B for construction site platform
3
Cyberstarts nets $60 million for fourth Seed fund
4
Fintech startup Obligo raises $35 million for security deposit solutions
5
OneStep secures $36 million Series B for smartphone-based motion analysis technology
More news
Cukierman
3 stories about Cukierman
Prepare for a year of M&As in Israeli life sciences companies
28.11.21
|
Laurent Choppe
Massive fund raising, significant growth in M&A deals and even a first Israeli biomed SPAC; Dr. Laurent Choppe, Managing Partner at Cukierman & Co. Life Sciences, explains the current trends behind the sector's amazing year and discusses what’s next
Israel third only to U.S. and China in Covid-19 solutions, says life sciences expert
17.07.20
|
Allon Sinai
"We don't talk anymore about devices or drugs. We talk about healthtech convergence, which for me is the future," explains Dr. Laurent Choppe, Managing Partner at Cukierman & Co. Life Sciences
U.S.-China Trade War an Opportunity for Israeli Tech, Says Venture Capitalist
31.10.19
|
Lilach Baumer
Edouard Cukierman of Cukierman & Co. and Catalyst sees potential in the mounting trade tensions between the U.S. and China, and thinks Israeli companies should steer clear of Chinese politics
Please ensure Javascript is enabled for purposes of
website accessibility